Defective nitric oxide production by alveolar macrophages during Pneumocystis pneumonia

American Journal of Respiratory Cell and Molecular Biology

Volumn 44, Issue 4, 2011, Pages 540-547

  Lasbury, Mark E ^a   Liao, Chung Ping ^a   Hage, Chadi A ^a   Durant, Pamela J ^a   Tschang, Dennis ^a   Wang, Shao Hung ^b   Zhang, Chen ^a   Lee, Chao Hung ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Alveolar macrophage; Calmodulin; iNOS; Nitric oxide; Pneumocystis

Indexed keywords

CALMODULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; MONOMER; NITRITE; ORNITHINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LYSATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIMERIZATION; ENZYME SYNTHESIS; FUNGUS CULTURE; HISTOPLASMA CAPSULATUM; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOBLOTTING; IMMUNOCOMPETENCE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; RAT;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL EXTRACTS; CELL LINE; CELL PROLIFERATION; COENZYMES; CULTURE MEDIA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MACROPHAGES, ALVEOLAR; MICE; MICROBIAL VIABILITY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; ORNITHINE; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; PROTEIN MULTIMERIZATION; RATS; TIME FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; MUS; PNEUMOCYSTIS; RATTUS;

EID: 79953748201     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0367OC     Document Type: Article

References (45)

1. Lasbury ME, Durant PJ, Ray CA, Tschang D, Schwendener R, Lee CH. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with Pneumocystis pneumonia. J Immunol 2006;176:6443-6453.
2. Limper AH, Hoyte JS, Standing JE. The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung. J Clin Invest 1997;99:2110-2117. (Pubitemid 27203767)
3. Ezekowitz RAB, Williams DJ, Koziel H, Armstrong MY, Warner A, Richards FF, Rose RM. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature 1991;351:155-158. (Pubitemid 21896556)
4. Masur H, Jones TC. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 1978;147:157-170. (Pubitemid 8250815)
5. Hidalgo HA, Helmke RJ, German VF, Mangos JA. Pneumocystis carinii induces an oxidative burst in alveolar macrophages. Infect Immun 1992;60:1-7.
6. Laursen AL, Møller B, Rungby J, Petersen CM, Andersen PL. Pneumocystis carinii-induced activation of the respiratory burst in human monocytes and macrophages. Clin Exp Immunol 1994;98:196-202. (Pubitemid 24336813)
7. Lasbury ME, Durant PJ, Bartlett MS, Smith JW, Lee CH. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Clin Diagn Lab Immunol 2003;10:293-302. (Pubitemid 36314455)
8. Lasbury ME, Tang X, Durant PJ, Lee CH. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun 2003;71:4943-4952. (Pubitemid 37070736)
9. Lasbury ME, Merali S, Durant PJ, Tschang D, Ray CA, Lee CH. Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia. J Biol Chem 2007;282:11009-11020.
10. Farley KS, Wang LF, Razavi HM, Law C, Rohan M, McCormack DG, Mehta S. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol 2006;290:L1164-L1172. (Pubitemid 43830861)
11. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001;2:907-916. (Pubitemid 32976162)
12. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J Immunol 1988;141:2407-2412.
13. Fleming SD, Iandolo JJ, Chapes SK. Murine macrophage activation by staphylococcal exotoxins. Infect Immun 1991;59:4049-4055.
14. Jun CD, Kim SH, Soh CT, Kang SS, Chung HT. Nitric oxide mediates the toxoplasmastatic activity of murine microglial cells in vitro. Immunol Invest 1993;22:487-501. (Pubitemid 23361560)
15. Liew FY, Li Y, Millott S. Tumour necrosis factor (TNF-alpha) in leishmaniasis: II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 1990;71:556-559.
16. Lee SC, Kress Y, Dickson DW, Casadevall A. Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody. J Neuroimmunol 1995;62:43-52.
17. Ke X, Terashima M, Nariai Y, Nakashima Y, Nabika T, Tanigawa Y. Nitric oxide regulates actin reorganization through cGMP and Ca(2+)/calmodulin in Raw 264.7 cells. Biochim Biophys Acta 2001;1539:101-113.
18. Lasbury ME, Durant PJ, Liao CP, Lee CH. Effects of decreased calmodulin protein on the survival mechanisms of alveolar macrophages during Pneumocystis pneumonia. Infect Immun 2009;77:3344-3354.
19. Sherman MP, Loro ML, Wong VZ, Tashkin DP. Cytokine- and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool 1991;38:234S-236S.
20. Downing JF, Kachel DL, Pasula R, Martin WJ II. Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun 1999;67:1347-1352. (Pubitemid 29108515)
21. Ishimine T, Kawakami K, Nakamoto A, Saito A. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol Immunol 1995;39:49-58.
22. Hanano R, Reifenberg K, Kaufmann SH. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect Immun 1998;66:305-314. (Pubitemid 28018834)
23. Shellito JE, Kolls JK, Olariu R, Beck JM. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J Infect Dis 1996;173:432-439. (Pubitemid 26042445)
24. Queener SF, Bartlett MS, Nasr M, Smith JW. 8-aminoquinolines effective against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother 1993;37:2166-2172. (Pubitemid 23298206)
25. + T cells. J Immunol 1999;162:2890-2894.
26. Lasbury ME, Lin P, Tschang D, Durant PJ, Lee CH. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages. Infect Immun 2004;72:2140-2147. (Pubitemid 38419927)
27. Worsham PL, Goldman WE. Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol 1988;26:137-143.
28. Wang SH, Zhang C, Lasbury ME, Liao CP, Durant PJ, Tschang D, Lee CH. Decreased inflammatory response in Toll-like receptor 2 knockout mice is associated with exacerbated Pneumocystis pneumonia. Microbes Infect 2008;10:334-341.
29. Zhang C, Wang SH, Lasbury ME, Tschang D, Liao CP, Durant PJ, Lee CH. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect Immun 2006;74:1857-1864. (Pubitemid 43346822)
30. Liao CP, Lasbury ME, Wang SH, Zhang C, Durant PJ, Murakami Y, Matsufuji S, Lee CH. Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages. J Biol Chem 2009;284:8174-8184.
31. Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J. Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 1998;95:7625-7630. (Pubitemid 28293303)
32. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophoton Int 2004;11:36-42.
33. Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA 1993;90:8103-8107. (Pubitemid 23260863)
34. Castillo L, deRojas TC, Chapman TE, Vogt J, Burke JF, Tannenbaum SR, Young VR. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA 1993;90:193-197.
35. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985;82:7738-7742. (Pubitemid 16204424)
36. Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hsieh CM, Kourembanas S, Lee ME. Transforming growth factor-β1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem 1994;269:14595-14600.
37. Blasko E, Glaser CB, Devlin JJ, Xia W, Feldman RI, Polokoff MA, Phillips GB, Whitlow M, Auld DS, McMillan K, et al. Mechanistic studies with potent and selective inducible nitric-oxide synthase dimerization inhibitors. J Biol Chem 2002;277:295-302. (Pubitemid 34952058)
38. Watts RN, Ponka P, Richardson DR. Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron. Biochem J 2003;369:429-440. (Pubitemid 36246225)
39. Taylor BS, Alarcon LH, Billiar TR. Inducible nitric oxide synthase in the liver: regulation and function. Biochemistry (Mosc) 1998;63:766-781. (Pubitemid 128588106)
40. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001;357:593-615. (Pubitemid 32735142)
41. Panda K, Rosenfeld RJ, Ghosh S, Meade AL, Getzoff ED, Stuehr DJ. Distinct dimer interaction and regulation in nitric-oxide synthase Types I, II, and III. J Biol Chem 2002;277:31020-31030. (Pubitemid 34970806)
42. Stuehr DJ, Kwon NS, Nathan CF, Griffith OW, Feldman PL, Wiseman J. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 1991;266:6259-6263. (Pubitemid 21906212)
43. Mayer B, Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 1997;22:477-481. (Pubitemid 27515914)
44. López A, Bernardo B, López-Herce J, Cristina AI, Carrillo A. Methaemoglobinaemia secondary to treatment with trimethoprim and sulphamethoxazole associated with inhaled nitric oxide. Acta Paediatr 1999;88:915-916. (Pubitemid 29439618)
45. Buratti T, Joannidis M, Pechlaner C, Wiedermann CJ. Systemic hypotension on withdrawal from inhaled nitric oxide in an adult patient with acute respiratory distress syndrome. Crit Care Med 1999;27:441. (Pubitemid 29113561)